Home › Chronic Lymphocytic Leukemia › California › Baldwin Park

Pag-aaral pangklinika para sa Chronic Lymphocytic Leukemia sa Baldwin Park, CA

16 pag-aaral para sa Chronic Lymphocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Baldwin Park (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Nagre-recruitPhase 3

Kaiser Permanente-Baldwin Park, Baldwin Park

Edad 65 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07321652

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Nagre-recruitPhase 3

Kaiser Permanente-Baldwin Park, Baldwin Park
City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT04269902

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

Nagre-recruitPhase 3

City of Hope National Medical Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07277231

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2

City of Hope, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221500

Testing the Effectiveness of the Anti-cancer Drug, Mirdametinib, in Treating Relapsed, Refractory Chronic Lymphocytic Leukemia

Nagre-recruitPhase 2

City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07061951

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2

City of Hope National Medical Center, Duarte · 4 mi ang layo

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Nagre-recruitPhase 1

City of Hope, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06528301

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

City of Hope, Duarte · 4 mi ang layo

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo

City of Hope Medical Center, Duarte · 4 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07020533

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

City of Hope, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT05131022

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Nagre-recruitPhase 2

City of Hope National Medical Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update May 19, 2026 · NCT06588478

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Nagre-recruitPhase 1

City of Hope Medical Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 20, 2026 · NCT06859008

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Nagre-recruitPhase 1/2

City of Hope, Duarte · 4 mi ang layo

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

City of Hope, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial

Nagre-recruitPhase 2

City of Hope Medical Center, Duarte · 4 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT07218510

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

City of Hope Medical Center, Duarte · 4 mi ang layo

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 10, 2026 · NCT06059391

Pag-aaral para sa Chronic Lymphocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Baldwin Park

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.